Home
>
National Drug Code (NDC)
>
Afeditab
Afeditab - 0591-3193-05 - (Nifedipine)
Drug Information of Afeditab
| Product NDC: | 0591-3193 |
| Proprietary Name: | Afeditab |
| Non Proprietary Name: | Nifedipine |
| Active Ingredient(s): | 30 mg/1 & nbsp; Nifedipine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Afeditab
| Product NDC: | 0591-3193 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075128 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20021101 |
Package Information of Afeditab
| Package NDC: | 0591-3193-05 |
| Package Description: | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0591-3193-05) |
NDC Information of Afeditab
| NDC Code | 0591-3193-05 |
| Proprietary Name | Afeditab |
| Package Description | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0591-3193-05) |
| Product NDC | 0591-3193 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Nifedipine |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20021101 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | NIFEDIPINE |
| Strength Number | 30 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |
